share_log

CASI Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-WEI-WU HE, Ph.D.(20.94%),EMERGING TECHNOLOGY PARTNERS, LLC(7.1%), etc.

CASI Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-WEI-WU HE, Ph.D.(20.94%),EMERGING TECHNOLOGY PARTNERS, LLC(7.1%), etc.

CASI製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-WEI-WU HE, Ph.D.(20.94%),EMERGING TECHNOLOGY PARTNERS, LLC(7.1%)等
美股SEC公告 ·  08/12 08:30
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息